Emerging evidence suggests that fibroblast growth factor-1 (FGF1), which induces adipocyte precursor differentiation through activation of the FGF-receptor-1 (31), has a beneficial effect in heart diseases. This evidence concerns the gene FGF1 and heart disorder.